Shudofsky, K., Abma, J., Driessen, J., Slikkerveer, M., Vanmolkot, F., Janssen, P., & le Noble, J. (2026). Association of Acute Kidney Injury and Chronic Kidney Disease With Concentration-To-Dose Ratios of Midazolam and Its Main Metabolites in Critically Ill Adults. Fundamental & Clinical Pharmacology, 40(4), Article e70108. https://doi.org/10.1111/fcp.70108

Spronk, S. H., Nielen, J. T. H., Heier, L., Jessurun, N., Kant, A., & Karapinar-Carkit, F. (2026). Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs of ACE inhibitors and ARBs. European Journal of Clinical Pharmacology, 82(6), Article 162. https://doi.org/10.1007/s00228-026-04088-6

Verdonschot, R. G., Dilles, T., Cahir, C., De Graef, M., Holis, R. V., Fryden, J., Denig, P., Grimes, T., Karapinar-Carkıt, F., & Schor, M. (2026). To include or not to include? A prescription from the pharmacy on how to use active learning-assisted screening in systematic reviews. Systematic Reviews, 15(1), Article 185. https://doi.org/10.1186/s13643-026-03185-y

Maathuis, J., Veldhuis, A., Egbers, J. B., Geerdink, J., Karapinar-Carkit, F., Van Den Bemt, P. M. L. A., Hulshof, E. C., & Kingma, J. S. (2026). Correction: Impact of an AI-powered hospital admission prediction dashboard to guide medication reconciliation in the emergency department: a retrospective before-after study (JAN , 10.1007/s11096-025-02076-x, 2026). International Journal of Clinical Pharmacy, 48(3), 1189. https://doi.org/10.1007/s11096-026-02100-8

Gundogan-Yilmaz, R., Wahedi, S., Driessen, J. H. M., Mohammad, A., Denig, P., & Karapinar-Carkit, F. (2026). Dose-dependent relationships in potential prescribing cascades: a cohort study using community pharmacy dispensing data. International Journal of Clinical Pharmacy, 48(3), 874-885. https://doi.org/10.1007/s11096-025-02083-y

Maathuis, J., Veldhuis, A., Egbers, J. B., Geerdink, J., Karapinar-Carkit, F., Van Den Bemt, P. M. L. A., Hulshof, E. C., & Kingma, J. S. (2026). Impact of an AI-powered hospital admission prediction dashboard to guide medication reconciliation in the emergency department: a retrospective before-after study. International Journal of Clinical Pharmacy, 48(3), 801-807. https://doi.org/10.1007/s11096-025-02076-x

Lanser, D. A. C., Heersche, N., Muntinghe-Wagenaar, M. B., Ali, M. I. M., Ulas, E. B., de Jonge, E., Oomen-de Hoop, E., Paats, M. S., Bahce, I., Croes, S., Langen, A. J., Hendriks, L. E. L., Wekken, A. J., Huitema, A. D. R., Schaik, R. H. N., Dingemans, A.-M. C., Veerman, G. D. M., & Mathijssen, R. H. J. (2026). Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer. Cancer Communications, 46, Article 0031. https://doi.org/10.34133/cancomm.0031

ten Hoope, S. M. K., Marongiu, S., Siegert, C. E. H., Heerdink, E. R., Janssen, M. J. A., & Karapinar-Çarkit, F. (2026). Conducting Medication Reviews: A Comparative Study Between ChatGPT-4 and Healthcare Professionals. Journal of the American Geriatrics Society, 74(5), 1378-1385. https://doi.org/10.1111/jgs.70415

Falke, C. M., Koolen, M. F. J., Timmer, S. L., Karapinar-carkit, F., Bouvy, M. L., Egberts, A. C. G., & Knol, W. (2026). Perspectives of Older Patients on the Complexity of Medication Use. Journal of the American Geriatrics Society, 74(5), 1255-1264. https://doi.org/10.1111/jgs.70311

Kingma, J. S., Loh, C., Eland, I. A., van den Broek, M. P. H., Derksen, W. J. M., Knibbe, C. A. J., Karapinar-Carkit, F., van den Bemt, P. M. L. A., & Burgers, D. M. T. (2026). The prevalence of medication-related hospital readmissions after bariatric surgery: a retrospective observational study. International Journal of Clinical Pharmacy, 48(2), 524-533. https://doi.org/10.1007/s11096-025-02017-8

Falke, C., Karapinar-Carkit, F., Knol, W., Bouvy, M., Egberts, T., Kempen, T., Vervloet, M., & Heringa, M. (2026). Patients' perspectives and experiences regarding medication reviews: A cross-sectional survey study. Exploratory Research in Clinical and Social Pharmacy, 21, Article 100692. https://doi.org/10.1016/j.rcsop.2025.100692

Visker, V. P., Kvist, A. V., Vestergaard, P., van den Bergh, J. P., Brouwers, M. C. J. G., Wyers, C. E., & Driessen, J. H. M. (2026). Fracture trends in Denmark from 1997 to 2021. Osteoporosis International, 37(2), 417-424. https://doi.org/10.1007/s00198-025-07746-0

Kruithof, P. D., Souverein, P. C., Driessen, J. H. M., Hendriks, L. E. L., Croes, S., & Van Geel, R. M. J. M. (2026). Concordance of Lung Cancer, Melanoma, and Renal Cell Cancer Diagnosis Information Recorded in Health Care Databases in England: Analysis of Linkage Between Primary Care, Hospital Care, and Cancer Registry Data. Pharmacoepidemiology and Drug Safety, 35(1), Article e70299. https://doi.org/10.1002/pds.70299

Mohammad, A. K., Driessen, J. H. M., Hugtenburg, J. G., Marmorale, A., Siegert, C., van den Bemt, P. M. L. A., Denig, P., & Karapinar-Carkit, F. (2026). Occurrence of Potential Prescribing Cascades After Hospital Discharge: A Cohort Study. Pharmacoepidemiology and Drug Safety, 35(1), Article e70305. https://doi.org/10.1002/pds.70305

van Oostwaard, M. M., Bevers, M. S. A. M., Driessen, J. H. M., de Jong, M., Heijnen, M. L. G. J., Wyers, C. E., & van den Bergh, J. P. (2025). Bone microarchitecture and strength in men with prostate cancer with and without prevalent vertebral fractures at the initiation of androgen deprivation therapy. Bone, 201, Article 117643. https://doi.org/10.1016/j.bone.2025.117643

Westra, N., Kruithof, P. D., Croes, S., van Geel, R. M. J. M., Hendriks, L. E. L., Touw, D. J., Kosterink, J. G. W., Stevens, J., Munnink, T. H. O., & Mian, P. (2025). Osimertinib Cost Minimization in Non-Small Cell Lung Cancer (NSCLC) Treatment: Hypothesis Generation for a Population Pharmacokinetic Approach for Equivalent Dose Optimization of Osimertinib in Combination With Cobicistat. Journal of Clinical Pharmacology, 65(12), 1687-1698. https://doi.org/10.1002/jcph.70085

Kruithof, P. D., Brouns, A. J. W. M., Degens, J. H. R. J., Hendriks, L. E. L., Wong, D. R., van Geel, R. M. J. M., & Croes, S. (2025). Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Case series. Clinical Lung Cancer, 26(7), e496-e502. https://doi.org/10.1016/j.cllc.2025.05.012

van der Linden, L., Beavers, C., Forsyth, P., Vandenbriele, C., Tsuyuki, R. T., Karapinar-Carkit, F., & Van Aelst, L. (2025). Effects of pharmacist care on hospitalizations in heart failure across outpatient and inpatient settings: A systematic review and meta-analysis. British Journal of Clinical Pharmacology, 91(11), 3021-3030. Article 70261. https://doi.org/10.1002/bcp.70261

Werkman, N. C. C., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simon, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., Bosma, H., Schram, M. T., van Greevenbroek, M. M. J., Wesselius, A., Stehouwer, C. D. A., Driessen, J. H. M., & Garcia-Saez, G. (2025). Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study. Diabetes Obesity & Metabolism, 27(10), 5524-5537. https://doi.org/10.1111/dom.16598

Juhasova, Z., Karapinar-Carkit, F., & Weir, D. L. (2025). The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study. British Journal of Clinical Pharmacology, 91(10), 2910-2918. https://doi.org/10.1002/bcp.70116

Keene, S. J., Driessen, J. H. M., Jordan, R. E., Sitch, A., Adab, P., & Franssen, F. M. E. (2025). The independent and combined effects of smoking and chronic obstructive pulmonary disease on body mass index trajectories. Scientific Reports, 15(1), Article 32883. https://doi.org/10.1038/s41598-025-17270-0

Stuijt, C. C. M., van den Bemt, B. J. F., Karapinar, F., & van Laar, T. (2025). Apotheekinterventies: Benader Het Anders. Pharmaceutisch Weekblad, 160(38), 10-12. https://www.pw.nl/achtergrond/2025/apotheekinterventies-benader-het-anders

de Rouw, N., Otten, L.-S., Kicken, M. P., Piet, B., Biesma, B., van Veggel, B., Steendam, C. M. J., van den Borne, B., Hendriks, L. E. L., Croes, S., Dingemans, A.-M. C., Dumoulin, D. W., Mathijssen, R. H. J., Burgers, J. A., Huitema, A. D. R., Derijks, H. J., Deenen, M. J., van den Heuvel, M. M., & ter Heine, R. (2025). Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment. Clinical Pharmacology & Therapeutics, 118(3), 715-722. https://doi.org/10.1002/cpt.3735

Ten Hoope, S., Welvaars, K., van Geijtenbeek, K., Klok-Everaars, M., van Schaik, S., & Karapinar-Çarkit, F. (2025). Applying text-mining to clinical notes: the identification of patient characteristics from electronic health records (EHRs). BMC Medical Informatics and Decision Making, 25(1), Article 302. https://doi.org/10.1186/s12911-025-03137-x

Adrien, O., Mohammad, A. K., Hugtenburg, J. G., Mccarthy, L. M., Priester-Vink, S., Visscher, R., van den Bemt, P. M. L. A., Denig, P., & Karapinar-Carkit, F. (2025). Correction: Prescribing Cascades with Recommendations to Prevent or Reverse Them: A Systematic Review (vol 40, pg 1085, 2023). Drugs & Aging, 42(7), 675-686. https://doi.org/10.1007/s40266-025-01213-5

Mohammad, A. K., Hugtenburg, J. G., Ceylan, Y., Kooij, M., Knies, S., van den Bemt, P. M. L. A., Denig, P., & Karapinar-Carkit, F. (2025). Pharmacy-led interventions to reverse and prevent prescribing cascades in primary care: a proof-of-concept study. International Journal of Clinical Pharmacy, 47(3), 784-793. Article e0272418. https://doi.org/10.1007/s11096-025-01873-8

Nielen, J. T. H., van der Walle, K., Spronk, S., Magdelijns, F., Denig, P., & Karapinar, F. (2025). Real-World Complexity of Prescribing Cascades. Basic & Clinical Pharmacology & Toxicology, 137(1), Article e70063. https://doi.org/10.1111/bcpt.70063

Heersche, N., Lanser, D. A. C., Muntinghe-Wagenaar, M. B., Mohmaed Ali, M. I., Ulas, E. B., Trooster, T. M. A., de Jonge, E., Oomen-de Hoop, E., Paats, M. S., Bahce, I., Croes, S., Hendriks, L. E. L., van der Wekken, A. J., Dingemans, A.-M. C., Huitema, A. D. R., van Schaik, R. H. N., Mathijssen, R. H. J., & Veerman, G. D. M. (2025). Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC. Journal of Thoracic Oncology, 20(4), 475-486. https://doi.org/10.1016/j.jtho.2024.11.025

Lips, N., Singh, A., Weir, D., & Karapinar-Carkit, F. (2025). Comparing the performance of multiple trigger tools in identifying medication-related hospital readmissions. Journal of the American Geriatrics Society, 73(1), 162-171. Article 19216. https://doi.org/10.1111/jgs.19216

Graafsma, J., van de Garde, E. M. W., Derijks, H. J., Hoge, R. H. L., Klopotowska, J. E., Karapinar-Carkit, F., van den Bemt, P. M. L. A., & Dutch CDSS-efficiency study group (2025). Efficiency of computerized clinical decision support systems involving anticoagulants: A flashmob study in Dutch hospital pharmacies. British Journal of Clinical Pharmacology, 91(1), 157-165. Article 16236. https://doi.org/10.1111/bcp.16236

Stuijt, C. C. M., Karapinar-carkit, F., van de Steeg-van Gompel, C., van Laar, T., van den Bemt, B. J. F., & Heringa, M. (2024). Feasibility of a Pharmabuddy Care Service for patients with Parkinson's disease. BMC Health Services Research, 24(1), Article 1560. https://doi.org/10.1186/s12913-024-12057-x

Hoope, S. T., Benlamkaddam, M., Koster, E., Duyvendakv, M., Abdullah-Koolmees, H., & Karapinar-Çarkit, F. (2024). De tijdsbelasting en uitvoering van medicatieverificatie voor (poli)klinische patiënten in Nederlandse ziekenhuizen. Pharmaceutisch Weekblad, 159(49), 21-27. https://www.npfo.nl/assets/article/downloads/a1788_28nov2024.pdf

Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). Correction: The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15(6), 1725-1730. https://doi.org/10.1007/s41999-024-01072-0

Mohammad, A. K., Hugtenburg, J. G., Vanhommerig, J. W., van den Bemt, P. M. L. A., Denig, P., & Karapinar-Carkit, F. (2024). Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed-methods study. Journal of the American Geriatrics Society, 72(12), 3681-3694. https://doi.org/10.1111/jgs.19191

Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O'Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine, 15(6), 1713-1723. https://doi.org/10.1007/s41999-024-01036-4

van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P., & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes Obesity & Metabolism, 26(11), 4887-4896. https://doi.org/10.1111/dom.15884

van Oostwaard, M. M., Wyers, C. E., Driessen, J. H. M., van Maren, M., de Jong, M., van de Wouw, A. J., Janssen-Heijnen, M. L. G., & van den Bergh, J. P. (2024). The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy. Osteoporosis International, 35(11), 2037-2045. https://doi.org/10.1007/s00198-024-07180-8

van de Plas, A., Tanis, W. J., Deneer, V. H. M., Olsder, G., van der Lee, M. J., Hunfeld, N. G. M., Duyvendak, M., Karapinar-Çarkit, F., Rennenberg, R., & van den Bemt, P. M. L. A. (2024). Risicogestuurde benadering overtroeft de dubbelcheck: Experts: nieuwe richtlijn nodig voor risicogestuurde aanpak bij toediening parenteralia. Pharmaceutisch Weekblad, 159(42), 19-21.

Talhaoui, S., Maier, M., Hugtenburg, J. G., Karapinar, F., & Kooij, M. J. (2024). Proactieve Aanpak Maakt Het Verschil Voor Hartpatiënt: Ervaringen van de Amsterdamse Therapietrouw Proeftuin. Pharmaceutisch Weekblad, 159(43), 22-25. https://www.pw.nl/achtergrond/2024/proactieve-aanpak-maakt-het-verschil-voor-hartpatient

Van Hulten, V., Driessen, J. H. M., Andersen, S., Kvist, A., Viggers, R., Bliuc, D., Center, J. R., Brouwers, M. C. J. G., Vestergaard, P., & van den Bergh, J. P. (2024). Fracture risk revisited: Bone mineral density T-score and fracture risk in type 2 diabetes. Diabetes Obesity & Metabolism, 26(11), 5325-5335. https://doi.org/10.1111/dom.15890

Van Hulten, V., Sarodnik, C., Driessen, J. H. M., Viggers, R., Rasmussen, N. H., Geusens, P. P. M. M., Schaper, N., Schram, M. T., De Galan, B. E., Koster, A., Bours, S. P. G., Vestergaard, P., Stehouwer, C. D. A., & van den Bergh, J. P. (2024). Bone microarchitecture and strength assessed by HRpQCT in individuals with type 2 diabetes and prediabetes: the Maastricht study. JBMR plus, 8(9), Article ziae086. https://doi.org/10.1093/jbmrpl/ziae086

Werkman, N. C. C., Driessen, J. H. M., Klungel, O. H., Schaper, N. S., Souverein, P. C., Stehouwer, C. D. A., & Nielen, J. T. H. (2024). Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes Obesity & Metabolism, 26(9), 3764-3780. https://doi.org/10.1111/dom.15721

Moes, D. J. A. R., Hendrikx, J. J. M. A., Guchelaar, H.-J., Mathijssen, R. H. J., Bakker, J. L., Dezentje, V. O., de Rouw, N., van Erp, N. P., Smit, E. F., van den Heuvel, M. M., Munnink, T. H. O., van Kats, M., Croes, S., Kroep, J. R., Zwaveling, J., & ter Heine, R. (2024). Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan. Targeted Oncology, 19(5), 789-796. https://doi.org/10.1007/s11523-024-01075-8

Gulikers, J. L., Otten, L.-S., Hendriks, L. E. L., Winckers, K., Henskens, Y., Leentjens, J., van den Heuvel, M. M., Ter Heine, R., Croes, S., Piet, B., & van Geel, R. M. J. M. (2024). Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer. British Journal of Cancer, 131(3), 481-490. https://doi.org/10.1038/s41416-024-02744-1

Rahman, R. N., Polinder, S., Nikolik, B., Hoek, A. E., Janssen, M. J. A., Schuit, S. C. E., van den Bemt, P. M. L. A., & Karapinar-Carkit, F. (2024). Medication reviews by emergency department pharmacists in patients hospitalised for an adverse drug event: a cost study. BMC Health Services Research, 24(1), Article 975. https://doi.org/10.1186/s12913-024-11346-9

Kruik-Kollöffel, W. J., Moltman, G. A. W., Wu, M. D., Braaksma, A., Karapinar, F., & Boucherie, R. J. (2024). Optimisation of medication reconciliation using queueing theory: a computer experiment. International Journal of Clinical Pharmacy, 46(4), 881-888. https://doi.org/10.1007/s11096-024-01722-0

Defieuw, L., Hias, J., Karapinar-Carkit, F., Forsyth, P., & Van der Linden, L. R. (2024). Empowering European hospital pharmacists in the face of heart failure. European Journal of Hospital Pharmacy - Science and Practice, 31(4), 287-288. https://doi.org/10.1136/ejhpharm-2023-004068

Westra, N., Kruithof, P. D., Croes, S., van Geel, R. M. J. M., Hendriks, L. E. L., Touw, D. J., Munnink, T. H. O., & Mian, P. (2024). Systematic Evaluation of Osimertinib Population Pharmacokinetic Models in a Cohort of Dutch Adults with Non-Small Cell Lung Cancer. European Journal of Drug Metabolism and Pharmacokinetics, 49(4), 517-526. https://doi.org/10.1007/s13318-024-00904-5

Graafsma, J., Klopotowska, J. E., Derijks, H. J., van de Garde, E. M. W., Hoge, R. H. L., Kruip, M. J. H. A., Meijer, K., Karapinar-Carkit, F., & van den Bemt, P. M. L. A. (2024). Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals. PLOS ONE, 19(6), Article e0306033. https://doi.org/10.1371/journal.pone.0306033